SCHEMBL21883774

SCHEMBL21883774

CCCCCCc1nccc(C#N)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.40
TSHR P16473 2/20 0.40
ALDH1A1 P00352 3/20 0.39
HPGD P15428 2/20 0.39
ESR1 P03372 2/20 0.39
ADRA2A P08913 2/20 0.39
ADORA3 P0DMS8 2/20 0.39
TACR2 P21452 2/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39
KDM4E B2RXH2 2/20 0.39
LMNA P02545 1/20 0.39
SHBG P04278 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
HSPD1 P10809 1/20 0.39
ADRB3 P13945 1/20 0.39
HTR2C P28335 1/20 0.39
HSPE1 P61604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21883663 0.83 TSHR (0.39) HSD17B10TSHRALDH1A1HPGDKDM4E
SCHEMBL19880572 0.83 KDM4E (0.41) HSD17B10TSHRALDH1A1HPGDKDM4E
SCHEMBL27781329 0.83 HPGD (0.41) HSD17B10TSHRALDH1A1HPGDKDM4E
SCHEMBL30805704 0.79 HPGD (0.50) HSD17B10TSHRALDH1A1HPGDKDM4E
Hydrochloric Acid SCHEMBL28530423 0.78 HPGD (0.49) HSD17B10TSHRALDH1A1HPGDKDM4E
SCHEMBL10376318 0.78 HPGD (0.38) HSD17B10TSHRALDH1A1HPGDKDM4E
Hydrochloric Acid SCHEMBL30805705 0.78 HPGD (0.49) HSD17B10TSHRALDH1A1HPGDKDM4E
SCHEMBL3313973 0.78 HPGD (0.51) HSD17B10TSHRALDH1A1HPGDKDM4E
SCHEMBL7215618 0.78 HPGD (0.42) ALDH1A1HPGDKDM4EL3MBTL1NPC1
SCHEMBL21883590 0.77 TYR (0.45) HSD17B10TSHRALDH1A1ESR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597377-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597377-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 HSD17B10 3787/4885TSHR 70/4885ALDH1A1 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.